125 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Ma J, Cao X, Xing X, Wang X, Parks JH. Adsorption of O2 on anionic silver clusters: spins and electron binding energies dominate in the range up to nano sizes. Physical Chemistry Chemical Physics : Pccp. PMID 26617113 DOI: 10.1039/c5cp06116d  0.56
2015 Xing X, Li X, Yoon B, Landman U, Parks JH. Dynamic fluxionality and enhanced CO adsorption in the presence of coadsorbed H2O on free gold cluster cations International Journal of Mass Spectrometry. 377: 393-402. DOI: 10.1016/j.ijms.2014.07.006  0.56
2013 Parks JH, Semrouni D, Clavaguéra C, Ohanessian G. Relationship between conformational dynamics and electron transfer in a desolvated peptide. Part II. Temperature dependence. The Journal of Physical Chemistry. B. 117: 1756-69. PMID 23297809 DOI: 10.1021/jp3078437  0.56
2013 Semrouni D, Clavaguéra C, Ohanessian G, Parks JH. Relationship between conformational dynamics and electron transfer in a desolvated peptide. Part I. Structures. The Journal of Physical Chemistry. B. 117: 1746-55. PMID 23297778 DOI: 10.1021/jp3078375  0.56
2011 Shi X, Ren J, Parks JH. Aldehyde complexes with protonated peptides in the gas phase. The Journal of Physical Chemistry. B. 115: 11183-92. PMID 21834583 DOI: 10.1021/jp112037a  0.56
2010 Shi X, Parks JH. Fluorescence lifetime probe of biomolecular conformations. Journal of the American Society For Mass Spectrometry. 21: 707-18. PMID 20188587 DOI: 10.1016/j.jasms.2010.01.009  0.56
2009 Parks JH, Coe FL. Evidence for durable kidney stone prevention over several decades. Bju International. 103: 1238-46. PMID 19021617 DOI: 10.1111/j.1464-410X.2008.08170.x  0.68
2009 Parks JH, Coe FL, Evan AP, Worcester EM. Clinical and laboratory characteristics of calcium stone-formers with and without primary hyperparathyroidism. Bju International. 103: 670-8. PMID 18793297 DOI: 10.1111/j.1464-410X.2008.08064.x  0.68
2009 Parks JH, Coe FL, Evan AP, Worcester EM. Urine pH in renal calcium stone formers who do and do not increase stone phosphate content with time. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 24: 130-6. PMID 18662977 DOI: 10.1093/ndt/gfn420  0.68
2008 Shi X, Duft D, Parks JH. Fluorescence quenching induced by conformational fluctuations in unsolvated polypeptides. The Journal of Physical Chemistry. B. 112: 12801-15. PMID 18793007 DOI: 10.1021/jp8033598  0.56
2008 Worcester EM, Coe FL, Evan AP, Bergsland KJ, Parks JH, Willis LR, Clark DL, Gillen DL. Evidence for increased postprandial distal nephron calcium delivery in hypercalciuric stone-forming patients. American Journal of Physiology. Renal Physiology. 295: F1286-94. PMID 18715937 DOI: 10.1152/ajprenal.90404.2008  0.68
2008 Coe FL, Parks JH, Evan A, Worcester E. Pathogenesis and Treatment of Nephrolithiasis Seldin and Giebisch's the Kidney. 1945-1977. DOI: 10.1016/B978-012088488-9.50071-1  0.68
2007 Iavarone AT, Patriksson A, van der Spoel D, Parks JH. Fluorescence probe of Trp-cage protein conformation in solution and in gas phase. Journal of the American Chemical Society. 129: 6726-35. PMID 17487969 DOI: 10.1021/ja065092s  0.56
2007 Worcester EM, Gillen DL, Evan AP, Parks JH, Wright K, Trumbore L, Nakagawa Y, Coe FL. Evidence that postprandial reduction of renal calcium reabsorption mediates hypercalciuria of patients with calcium nephrolithiasis. American Journal of Physiology. Renal Physiology. 292: F66-75. PMID 17210796 DOI: 10.1152/ajprenal.00115.2006  0.68
2007 Parks JH, Xing X. Chapter 9 Trapped ion electron diffraction: structural evolution of silver and gold clusters Chemical Physics of Solid Surfaces. 12: 377-407. DOI: 10.1016/S1571-0785(07)12009-5  0.56
2006 Iavarone AT, Duft D, Parks JH. Shedding light on biomolecule conformational dynamics using fluorescence measurements of trapped ions. The Journal of Physical Chemistry. A. 110: 12714-27. PMID 17125284 DOI: 10.1021/jp064933e  0.56
2006 Worcester EM, Parks JH, Evan AP, Coe FL. Renal function in patients with nephrolithiasis. The Journal of Urology. 176: 600-3; discussion 60. PMID 16813897 DOI: 10.1016/j.juro.2006.03.095  0.68
2006 Worcester EM, Coe FL, Evan AP, Parks JH. Reduced renal function and benefits of treatment in cystinuria vs other forms of nephrolithiasis. Bju International. 97: 1285-90. PMID 16686727 DOI: 10.1111/j.1464-410X.2006.06169.x  0.68
2006 Xing X, Yoon B, Landman U, Parks JH. Structural evolution of Au nanoclusters: From planar to cage to tubular motifs Physical Review B - Condensed Matter and Materials Physics. 74. DOI: 10.1103/PhysRevB.74.165423  0.56
2006 Iavarone AT, Meinen J, Schulze S, Parks JH. Fluorescence probe of polypeptide conformational dynamics in gas phase and in solution International Journal of Mass Spectrometry. 253: 172-180. DOI: 10.1016/j.ijms.2005.11.026  0.56
2005 Schooss D, Blom MN, Parks JH, v Issendorff B, Haberland H, Kappes MM. The structures of Ag55+ and Ag55- : trapped ion electron diffraction and density functional theory. Nano Letters. 5: 1972-7. PMID 16218720 DOI: 10.1021/nl0513434  0.56
2005 Iavarone AT, Parks JH. Conformational change in unsolvated Trp-cage protein probed by fluorescence. Journal of the American Chemical Society. 127: 8606-7. PMID 15954761 DOI: 10.1021/ja051788u  0.56
2005 O'Connor RC, Worcester EM, Evan AP, Meehan S, Kuznetsov D, Laven B, Sommer AJ, Bledsoe SB, Parks JH, Coe FL, Grynpas M, Gerber GS. Nephrolithiasis and nephrocalcinosis in rats with small bowel resection. Urological Research. 33: 105-15. PMID 15815943 DOI: 10.1007/s00240-004-0460-4  0.68
2005 Evan AP, Lingeman JE, Coe FL, Shao Y, Parks JH, Bledsoe SB, Phillips CL, Bonsib S, Worcester EM, Sommer AJ, Kim SC, Tinmouth WW, Grynpas M. Crystal-associated nephropathy in patients with brushite nephrolithiasis. Kidney International. 67: 576-91. PMID 15673305 DOI: 10.1111/j.1523-1755.2005.67114.x  0.68
2005 Kim SC, Coe FL, Tinmouth WW, Kuo RL, Paterson RF, Parks JH, Munch LC, Evan AP, Lingeman JE. Stone formation is proportional to papillary surface coverage by Randall's plaque. The Journal of Urology. 173: 117-9; discussion 11. PMID 15592050 DOI: 10.1097/01.ju.0000147270.68481.ce  0.68
2005 Xing X, Danell RM, Garzón IL, Michaelian K, Blom MN, Burns MM, Parks JH. Size-dependent fivefold and icosahedral symmetry in silver clusters Physical Review B - Condensed Matter and Materials Physics. 72. DOI: 10.1103/PhysRevB.72.081405  0.56
2004 Favus MJ, Karnauskas AJ, Parks JH, Coe FL. Peripheral blood monocyte vitamin D receptor levels are elevated in patients with idiopathic hypercalciuria. The Journal of Clinical Endocrinology and Metabolism. 89: 4937-43. PMID 15472188 DOI: 10.1210/jc.2004-0412  0.68
2004 Parks JH, Worcester EM, Coe FL, Evan AP, Lingeman JE. Clinical implications of abundant calcium phosphate in routinely analyzed kidney stones. Kidney International. 66: 777-85. PMID 15253733 DOI: 10.1111/j.1523-1755.2004.00803.x  0.68
2004 Weber JM, Ioffe IN, Berndt KM, Löffler D, Friedrich J, Ehrler OT, Danell AS, Parks JH, Kappes MM. Photoelectron spectroscopy of isolated multiply negatively charged oligonucleotides. Journal of the American Chemical Society. 126: 8585-9. PMID 15238018 DOI: 10.1021/ja049736c  0.56
2004 Maalouf NM, Sakhaee K, Parks JH, Coe FL, Adams-Huet B, Pak CY. Association of urinary pH with body weight in nephrolithiasis. Kidney International. 65: 1422-5. PMID 15086484 DOI: 10.1111/j.1523-1755.2004.00522.x  0.68
2004 Mardis HK, Parks JH, Muller G, Ganzel K, Coe FL. Outcome of metabolic evaluation and medical treatment for calcium nephrolithiasis in a private urological practice. The Journal of Urology. 171: 85-8. PMID 14665850 DOI: 10.1097/01.ju.0000099789.99127.6b  0.68
2003 Danell AS, Parks JH. Fraying and electron autodetachment dynamics of trapped gas phase oligonucleotides. Journal of the American Society For Mass Spectrometry. 14: 1330-9. PMID 14652182 DOI: 10.1016/S1044-0305(03)00578-6  0.56
2003 Worcester E, Parks JH, Josephson MA, Thisted RA, Coe FL. Causes and consequences of kidney loss in patients with nephrolithiasis. Kidney International. 64: 2204-13. PMID 14633144 DOI: 10.1046/j.1523-1755.2003.00317.x  0.68
2003 Kuo RL, Lingeman JE, Evan AP, Paterson RF, Parks JH, Bledsoe SB, Munch LC, Coe FL. Urine calcium and volume predict coverage of renal papilla by Randall's plaque. Kidney International. 64: 2150-4. PMID 14633137 DOI: 10.1046/j.1523-1755.2003.00316.x  0.68
2003 Parks JH, Coe FL. Thiazide does not affect urine oxalate excretion. The Journal of Urology. 170: 393-6. PMID 12853783 DOI: 10.1097/01.ju.0000076371.92938.9b  0.68
2003 Parks JH, Barsky R, Coe FL. Gender differences in seasonal variation of urine stone risk factors. The Journal of Urology. 170: 384-8. PMID 12853781 DOI: 10.1097/01.ju.0000071721.91229.27  0.68
2003 Asplin JR, Bauer KA, Kinder J, Müller G, Coe BJ, Parks JH, Coe FL. Bone mineral density and urine calcium excretion among subjects with and without nephrolithiasis. Kidney International. 63: 662-9. PMID 12631132 DOI: 10.1046/j.1523-1755.2003.00763.x  0.68
2003 Evan AP, Lingeman JE, Coe FL, Parks JH, Bledsoe SB, Shao Y, Sommer AJ, Paterson RF, Kuo RL, Grynpas M. Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. The Journal of Clinical Investigation. 111: 607-16. PMID 12618515 DOI: 10.1172/JCI17038  0.68
2003 Parks JH, Goldfischer ER, Coe FL. Changes in urine volume accomplished by physicians treating nephrolithiasis. The Journal of Urology. 169: 863-6. PMID 12576800 DOI: 10.1097/01.ju.0000044922.22478.32  0.68
2003 Parks JH, Worcester EM, O'Connor RC, Coe FL. Urine stone risk factors in nephrolithiasis patients with and without bowel disease. Kidney International. 63: 255-65. PMID 12472791 DOI: 10.1046/j.1523-1755.2003.00725.x  0.68
2003 Danell AS, Parks JH. FRET measurements of trapped oligonucleotide duplexes International Journal of Mass Spectrometry. 229: 35-45. DOI: 10.1016/S1387-3806(03)00253-7  0.56
2002 Khoury JT, Rodriguez-Cruz SE, Parks JH. Pulsed fluorescence measurements of trapped molecular ions with zero background detection. Journal of the American Society For Mass Spectrometry. 13: 696-708. PMID 12056569 DOI: 10.1016/S1044-0305(02)00364-1  0.56
2002 Asplin JR, Parks JH, Nakagawa Y, Coe FL. Reduced crystallization inhibition by urine from women with nephrolithiasis. Kidney International. 61: 1821-9. PMID 11967033 DOI: 10.1046/j.1523-1755.2002.00307.x  0.68
2002 Coe FL, Parks JH. Does a failure of crystal inhibition cause calcium renal stones? Nephron. 90: 361-4. PMID 11961392 DOI: 10.1159/000054721  0.68
2002 Kinder JM, Clark CD, Coe BJ, Asplin JR, Parks JH, Coe FL. Urinary stone risk factors in the siblings of patients with calcium renal stones. The Journal of Urology. 167: 1965-7. PMID 11956418  0.68
2002 Parks JH, Goldfisher E, Asplin JR, Coe FL. A single 24-hour urine collection is inadequate for the medical evaluation of nephrolithiasis. The Journal of Urology. 167: 1607-12. PMID 11912373  0.68
2002 Danell AS, Khoury JT, Parks JH. Combining FRET and mass spectrometry to study the dissociation of doublestranded oligonucleotide anions Proceedings 50th Asms Conference On Mass Spectrometry and Allied Topics. 123-124.  0.56
2001 Parks JH, Asplin JR, Coe FL. Patient adherence to long-term medical treatment of kidney stones. The Journal of Urology. 166: 2057-60. PMID 11696706  0.68
2001 Coe FL, Wise H, Parks JH, Asplin JR. Proportional reduction of urine supersaturation during nephrolithiasis treatment. The Journal of Urology. 166: 1247-51. PMID 11547051  0.68
2001 Coe FL, Clark C, Parks JH, Asplin JR. Solid phase assay of urine cystine supersaturation in the presence of cystine binding drugs. The Journal of Urology. 166: 688-93. PMID 11458118  0.68
2001 Coe FL, Wise H, Parks JH, Fleury PJ, Asplin JR. Differences in urine volume and supersaturation in 2 physician networks. The Journal of Urology. 166: 423-8. PMID 11458041  0.68
2001 Rodriguez-Cruz SE, Khoury JT, Parks JH. Protein fluorescence measurements within electrospray droplets. Journal of the American Society For Mass Spectrometry. 12: 716-25. PMID 11401162 DOI: 10.1016/S1044-0305(01)00241-0  0.56
2000 Nakagawa Y, Asplin JR, Goldfarb DS, Parks JH, Coe FL. Clinical use of cystine supersaturation measurements. The Journal of Urology. 164: 1481-5. PMID 11025687  0.68
2000 Krückeberg S, Schooss D, Maier-Borst M, Parks JH. Diffraction of trapped (CsI)nCs+: The appearance of bulk structure Physical Review Letters. 85: 4494-4497. DOI: 10.1103/PhysRevLett.85.4494  0.56
1999 Shahinfar S, Simpson RL, Carides AD, Thiyagarajan B, Nakagawa Y, Umans JG, Parks JH, Coe FL. Safety of losartan in hypertensive patients with thiazide-induced hyperuricemia. Kidney International. 56: 1879-85. PMID 10571797 DOI: 10.1046/j.1523-1755.1999.00739.x  0.68
1999 Asplin JR, Parks JH, Chen MS, Lieske JC, Toback FG, Pillay SN, Nakagawa Y, Coe FL. Reduced crystallization inhibition by urine from men with nephrolithiasis. Kidney International. 56: 1505-16. PMID 10504502 DOI: 10.1046/j.1523-1755.1999.00682.x  0.68
1999 Lingeman J, Kahnoski R, Mardis H, Goldfarb DS, Grasso M, Lacy S, Scheinman SJ, Asplin JR, Parks JH, Coe FL. Divergence between stone composition and urine supersaturation: clinical and laboratory implications. The Journal of Urology. 161: 1077-81. PMID 10081841 DOI: 10.1016/S0022-5347(01)61594-5  0.68
1999 Maier-Borst M, Cameron DB, Rokni M, Parks JH. Electron diffraction of trapped cluster ions Physical Review a - Atomic, Molecular, and Optical Physics. 59: R3162-R3165.  0.56
1998 Lingeman J, Mardis H, Kahnoski R, Goldfarb DS, Lacy S, Grasso M, Scheinman SJ, Parks JH, Asplin JR, Coe FL. Medical reduction of stone risk in a network of treatment centers compared to a research clinic. The Journal of Urology. 160: 1629-34. PMID 9783920 DOI: 10.1016/S0022-5347(01)62365-6  0.68
1998 Asplin JR, Lingeman J, Kahnoski R, Mardis H, Parks JH, Coe FL, Dore BR. Re: Metabolic urinary correlates of calcium oxalate dihydrate in renal stones [1] Journal of Urology. 160: 837. PMID 9720565  0.68
1998 Asplin J, Parks J, Lingeman J, Kahnoski R, Mardis H, Lacey S, Goldfarb D, Grasso M, Coe F. Supersaturation and stone composition in a network of dispersed treatment sites. The Journal of Urology. 159: 1821-5. PMID 9598467  0.68
1998 Goldfarb DS, Parks JH, Coe FL. Renal stone disease in older adults. Clinics in Geriatric Medicine. 14: 367-81. PMID 9536110  0.68
1998 Asplin JR, Lingeman J, Kahnoski R, Mardis H, Parks JH, Coe FL. Metabolic urinary correlates of calcium oxalate dihydrate in renal stones. The Journal of Urology. 159: 664-8. PMID 9474121 DOI: 10.1016/S0022-5347(01)63696-6  0.68
1998 Asplin JR, Arsenault D, Parks JH, Coe FL, Hoyer JR. Contribution of human uropontin to inhibition of calcium oxalate crystallization. Kidney International. 53: 194-9. PMID 9453018 DOI: 10.1046/j.1523-1755.1998.00739.x  0.68
1997 Asplin JR, Parks JH, Coe FL. Dependence of upper limit of metastability on supersaturation in nephrolithiasis. Kidney International. 52: 1602-8. PMID 9407506  0.68
1997 Coe FL, Parks JH. New insights into the pathophysiology and treatment of nephrolithiasis: new research venues. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 12: 522-33. PMID 9101363 DOI: 10.1359/jbmr.1997.12.4.522  0.68
1997 Coe FL, Parks JH, Favus MJ. Diet and calcium: the end of an era? Annals of Internal Medicine. 126: 553-5. PMID 9092322  0.68
1997 Parks JH, Coward M, Coe FL. Correspondence between stone composition and urine supersaturation in nephrolithiasis. Kidney International. 51: 894-900. PMID 9067927  0.68
1997 Asplin JR, Bushinsky DA, Singharetnam W, Riordon D, Parks JH, Coe FL. Relationship between supersaturation and crystal inhibition in hypercalciuric rats. Kidney International. 51: 640-5. PMID 9067894  0.68
1997 Cameron DB, Parks JH. Charge-exchange collisions of Czt 60: A probe of the ion charge distribution Chemical Physics Letters. 272: 18-24.  0.56
1996 Parks JH, Coe FL. The financial effects of kidney stone prevention. Kidney International. 50: 1706-12. PMID 8914040  0.68
1996 Parks JH, Coe FL. Pathogenesis and treatment of calcium stones. Seminars in Nephrology. 16: 398-411. PMID 8890396  0.68
1996 Porile JL, Asplin JR, Parks JH, Nakagawa Y, Coe FL. Normal calcium oxalate crystal growth inhibition in severe calcium oxalate nephrolithiasis. Journal of the American Society of Nephrology : Jasn. 7: 602-7. PMID 8724894  0.68
1996 Pollack S, Cameron D, Rokni M, Hill W, Parks JH. Charge exchange and cluster formation in an rf Paul trap: Interaction of alkali atoms with C+ 60 Chemical Physics Letters. 256: 101-108.  0.56
1995 Parks JH, Szöke A. Simulation of collisional relaxation of trapped ion clouds in the presence of space charge fields The Journal of Chemical Physics. 103: 1422-1439.  0.56
1994 Parks JH, Coe FL. An increasing number of calcium oxalate stone events worsens treatment outcome. Kidney International. 45: 1722-30. PMID 7933820  0.68
1994 Coe FL, Parks JH. Idiopathic hypercalciuria: the contribution of Dr. Jacob Lemann, Jr. Journal of the American Society of Nephrology : Jasn. 5: S59-69. PMID 7873747  0.68
1994 Coe FL, Nakagawa Y, Asplin J, Parks JH. Role of nephrocalcin in inhibition of calcium oxalate crystallization and nephrolithiasis. Mineral and Electrolyte Metabolism. 20: 378-84. PMID 7783700  0.68
1994 Parks JH, Pollack S, Hill W. Cluster experiments in radio frequency Paul traps: Collisional relaxation and dissociation The Journal of Chemical Physics. 101: 6666-6685.  0.56
1993 Sherrard DJ, Aguado JM, Morales JM, Brezis M, Cappuccio FP, MacGregor GA, Coe FL, Parks JH, Asplin JR. The pathogenesis and treatment of kidney stones [4] New England Journal of Medicine. 328: 444-445. PMID 8421468 DOI: 10.1056/NEJM199302113280617  0.68
1992 Coe FL, Parks JH, Webb DR. Stone-forming potential of milk or calcium-fortified orange juice in idiopathic hypercalciuric adults. Kidney International. 41: 139-42. PMID 1593849  0.68
1992 Coe FL, Parks JH, Asplin JR. The pathogenesis and treatment of kidney stones. The New England Journal of Medicine. 327: 1141-52. PMID 1528210 DOI: 10.1056/NEJM199210153271607  0.68
1991 Coe FL, Parks JH. Hereditary aspects of calcium nephrolithiasis. Advances in Nephrology From the Necker Hospital. 20: 31-40. PMID 2063720  0.68
1991 Coe FI, Parks JH, Nakagawa Y. Protein inhibitors of crystallization. Seminars in Nephrology. 11: 98-109. PMID 2034929  0.68
1991 Hess B, Nakagawa Y, Parks JH, Coe FL. Molecular abnormality of Tamm-Horsfall glycoprotein in calcium oxalate nephrolithiasis. The American Journal of Physiology. 260: F569-78. PMID 2012207  0.68
1991 Coe FL, Nakagawa Y, Parks JH. Inhibitors within the nephron. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 17: 407-13. PMID 2008908  0.68
1990 Coe F, Parks JH. Defenses of an unstable compromise: crystallization inhibitors and the kidney's role in mineral regulation. Kidney International. 38: 625-31. PMID 2232503  0.68
1989 Parks JH, McDonald SA. Evolution of the collective-mode resonance in small adsorbed sodium clusters. Physical Review Letters. 62: 2301-2304. PMID 10039909 DOI: 10.1103/PhysRevLett.62.2301  0.56
1989 Maikranz P, Holley JL, Parks JH, Lindheimer MD, Nakagawa Y, Coe FL. Gestational hypercalciuria causes pathological urine calcium oxalate supersaturations. Kidney International. 36: 108-13. PMID 2811052  0.68
1989 Coe FL, Parks JH. The risks of oral contraceptives and estrogen replacement therapy. Perspectives in Biology and Medicine. 33: 86-106. PMID 2689999  0.68
1988 Coe FL, Parks JH, Bushinsky DA, Langman CB, Favus MJ. Chlorthalidone promotes mineral retention in patients with idiopathic hypercalciuria. Kidney International. 33: 1140-6. PMID 3404813  0.68
1988 Coe FL, Parks JH. Pathophysiology of kidney stones and strategies for treatment. Hospital Practice (Office Ed.). 23: 185-9, 193-5, 199-20. PMID 3126203  0.68
1987 Maikranz P, Coe FL, Parks J, Lindheimer MD. Nephrolithiasis in pregnancy American Journal of Kidney Diseases. 9: 354-358. PMID 3555009  0.68
1987 Kristensen C, Parks JH, Lindheimer M, Coe FL. Reduced glomerular filtration rate and hypercalciuria in primary struvite nephrolithiasis. Kidney International. 32: 749-53. PMID 3430961  0.68
1987 Maikranz P, Coe FL, Parks JH, Lindheimer MD. Nephrolithiasis and gestation. BaillièRe's Clinical Obstetrics and Gynaecology. 1: 909-19. PMID 3330492 DOI: 10.1016/S0950-3552(87)80041-X  0.68
1986 Parks JH, Coe FL. A urinary calcium-citrate index for the evaluation of nephrolithiasis. Kidney International. 30: 85-90. PMID 3747347  0.68
1986 Coe FL, Favus MJ, Parks JH. Is estrogen preferable to surgery for postmenopausal women with primary hyperparathyroidism? The New England Journal of Medicine. 314: 1508-9. PMID 3702965 DOI: 10.1056/NEJM198606053142309  0.68
1986 Parks JH, Coe FL. Urine citrate and calcium in calcium nephrolithiasis. Advances in Experimental Medicine and Biology. 208: 445-9. PMID 3565157  0.68
1986 Coe FL, Parks JH. Recurrent renal calculi. Causes and prevention. Hospital Practice (Office Ed.). 21: 49-57. PMID 3081562  0.68
1985 Nakagawa Y, Abram V, Parks JH, Lau HS, Kawooya JK, Coe FL. Urine glycoprotein crystal growth inhibitors. Evidence for a molecular abnormality in calcium oxalate nephrolithiasis. The Journal of Clinical Investigation. 76: 1455-62. PMID 4056037 DOI: 10.1172/JCI112124  0.68
1985 Sutherland JW, Parks JH, Coe FL. Recurrence after a single renal stone in a community practice. Mineral and Electrolyte Metabolism. 11: 267-9. PMID 4033604  0.68
1985 Nakagawa Y, Parks JH, Kézdy FJ, Coe FL. Molecular abnormality of urinary glycoprotein crystal growth inhibitor in calcium nephrolithiasis. Transactions of the Association of American Physicians. 98: 281-9. PMID 3842199  0.68
1984 Mandl A, Klimek D, Parks JH. KrF laser kinetics studies Journal of Applied Physics. 55: 3940-3949. DOI: 10.1063/1.332980  0.56
1982 Millman S, Strauss AL, Parks JH, Coe FL. Pathogenesis and clinical course of mixed calcium oxalate and uric acid nephrolithiasis. Kidney International. 22: 366-70. PMID 7176335  0.68
1982 Parks JH, Coe FL, Strauss AL. Calcium nephrolithiasis and medullary sponge kidney in women. The New England Journal of Medicine. 306: 1088-91. PMID 7070404 DOI: 10.1056/NEJM198205063061805  0.68
1982 Strauss AL, Coe FL, Parks JH. Formation of a single calcium stone of renal origin. Clinical and laboratory characteristics of patients. Archives of Internal Medicine. 142: 504-7. PMID 7065787 DOI: 10.1001/archinte.1982.00340160084019  0.68
1982 Strauss AL, Coe FL, Deutsch L, Parks JH. Factors that predict relapse of calcium nephrolithiasis during treatment: a prospective study. The American Journal of Medicine. 72: 17-24. PMID 7058820 DOI: 10.1016/0002-9343(82)90566-6  0.68
1982 Bushinsky DA, Coe FL, Katzenberg C, Szidon JP, Parks JH. Arterial PCO2 in chronic metabolic acidosis. Kidney International. 22: 311-4. PMID 6816981  0.68
1982 Coe FL, Favus MJ, Crockett T, Strauss AL, Parks JH, Porat A, Gantt CL, Sherwood LM. Effects of low-calcium diet on urine calcium excretion, parathyroid function and serum 1,25(OH)2D3 levels in patients with idiopathic hypercalciuria and in normal subjects. The American Journal of Medicine. 72: 25-32. PMID 6277190 DOI: 10.1016/0002-9343(82)90567-8  0.68
1981 Coe FL, Parks JH. Hyperuricosuria and calcium nephrolithiasis. The Urologic Clinics of North America. 8: 227-44. PMID 7268958  0.68
1981 Parks JH. Angular multiplex laser fusion drivers Proceedings of Spie - the International Society For Optical Engineering. 270: 81-92. DOI: 10.1117/12.931739  0.56
1981 Parks JH, Coe FL, Millman S. Stone disease in idiopathic hypercalciuria Seminars in Nephrology. 1: 366-375.  0.68
1980 Parks J, Coe F, Favus M. Hyperparathyroidism in Nephrolithiasis Archives of Internal Medicine. 140: 1479-1481. PMID 7436644 DOI: 10.1001/archinte.1980.00330220049018  0.68
1980 Coe FL, Parks JH. Stone disease in hereditary distal renal tubular acidosis. Annals of Internal Medicine. 93: 60-1. PMID 7396320  0.68
1980 Coe FL, Parks JH, Strauss AL. Acclerated calcium nephrolithiasis. Jama. 244: 809-10. PMID 7392192 DOI: 10.1001/jama.1980.03310080043025  0.68
1980 Mandl A, Parks JH, Roxlo C. Collisional quenching kinetics for the HgCl* and HgBr* (B1/2) state The Journal of Chemical Physics. 72: 504-507.  0.56
1979 Mandl A, Parks JH. Device for quenching studies on rare gas and metal halide excited complexes. The Review of Scientific Instruments. 50: 127. PMID 18699350 DOI: 10.1063/1.1135655  0.56
1979 Coe FL, Parks JH, Moore ES. Familial idiopathic hypercalciuria. The New England Journal of Medicine. 300: 337-40. PMID 759893 DOI: 10.1056/NEJM197902153000703  0.68
1979 Weber DV, Coe FL, Parks JH, Dunn MS, Tembe V. Urinary saturation measurements in calcium nephrolithiasis. Annals of Internal Medicine. 90: 180-4. PMID 443649  0.68
1979 Slater RC, Parks JH. Non-thermal laser induced chemistry at high reactant gas pressures Chemical Physics Letters. 60: 275-278. DOI: 10.1016/0009-2614(79)80032-9  0.56
1978 Coe FL, Parks JH, Lindheimer MD. Nephrolithiasis during pregnancy. The New England Journal of Medicine. 298: 324-6. PMID 622090 DOI: 10.1056/NEJM197802092980608  0.68
1978 Mandl A, Parks JH. Collisional quenching kinetics for the HgCl* (B1/2) state Applied Physics Letters. 33: 498-500. DOI: 10.1063/1.90438  0.56
1978 Coe FL, Parks JH, Lindheimer MD. Pathology of pregnancy, labor and puerperium: Nephrolithiasis during pregnancy Obstetrical and Gynecological Survey. 33: 591-592.  0.68
1977 Parks JH. Laser action on the B2Σ+ 1/2→ X2Σ+ 1/2 band of HgBr at 5018 Å Applied Physics Letters. 31: 297-300. DOI: 10.1063/1.89676  0.56
1977 Parks JH. Laser action on the B2Σ+ 1/2→ X2Σ+ 1/2 band of HgCl at 5576 Å Applied Physics Letters. 31: 192-194. DOI: 10.1063/1.89644  0.56
Show low-probability matches.